Home

Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 25/03/10

Trade details

Type
Insider sale
Amount
$79,827.93
Shares · price
6,669 sh · $11.97 a share
Held after
287,811 sh
Trade date
25/03/07
Filed
25/03/10
Days to filing
3 days

Sold 2.3% of holdings

Share of holding sold
2.3%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/05~25/04/06

Benjamin L. Palleiko's recent trades

  • Benjamin L. Palleiko

    SellKalVista Pharmaceuticals

    $292.6K

    Filed 05/26

  • Benjamin L. Palleiko

    SellKalVista Pharmaceuticals

    $30.2K

    Filed 05/19

  • Benjamin L. Palleiko

    SellKalVista Pharmaceuticals

    $88.7K

    Filed 05/13

  • Benjamin L. Palleiko

    SellKalVista Pharmaceuticals

    $193.1K

    Filed 04/20

  • Benjamin L. Palleiko

    SellKalVista Pharmaceuticals

    $107.6K

    Filed 03/10

Benjamin L. Palleiko, CEO — sold $79.8K of KalVista Pharmaceuticals KALV · 2.3% of holdings | Whalegun